Skip to content
  • Saturday, 12 September 2026
  • 6:38 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Sidewinder Therapeutics Secures $137 Million in Series B Financing to Advance Bispecific Antibody-Drug Conjugate Pipeline
Pharmaceutical R&D

Sidewinder Therapeutics Secures $137 Million in Series B Financing to Advance Bispecific Antibody-Drug Conjugate Pipeline

Teuku Ryan Apr 8, 2026 0

Sidewinder Therapeutics has announced the successful closure of a substantial $137 million Series B financing round, a significant development signaling…

Read More
Stem Cell & Regenerative Medicine

Indiana University School of Medicine Scientists Develop Breakthrough Imaging Technique for Bone Marrow Analysis to Advance Disease Treatment

Dwi Wanna Apr 3, 2026 0

The landscape of hematological research and regenerative medicine has undergone a significant transformation following a major technological breakthrough by researchers…

Read More
Stem Cell & Regenerative Medicine

University of Basel Researchers Replicate Human Bone Marrow in Landmark Study to Advance Blood Cancer Research and Reduce Animal Testing

Dwi Wanna Mar 30, 2026 0

In a significant breakthrough for regenerative medicine and oncology, researchers at the University of Basel and University Hospital Basel have…

Read More
Pharmaceutical R&D

Cognito Therapeutics and Ochsner Health Forge Landmark Partnership to Advance Brain Health Innovation in the Gulf South

Teuku Ryan Mar 26, 2026 0

A groundbreaking collaboration has been established between US-based neurotechnology firm Cognito Therapeutics and Ochsner Health, a leading integrated healthcare system…

Read More
Neuroscience & Brain Research

Washington University Researchers Develop p-tau217 Blood Test Clock Capable of Predicting Alzheimer’s Symptom Onset Years in Advance

Rifan Muazin Mar 24, 2026 0

In a significant advancement for neurodegenerative disease research, scientists at Washington University School of Medicine in St. Louis have pioneered…

Read More
Pharmaceutical R&D

Congruence secures $39.5m to advance small molecule correctors pipeline

Teuku Ryan Mar 21, 2026 0

Congruence Therapeutics, a pioneering biotechnology company focused on developing novel small molecule correctors, has successfully closed a significant $39.5 million…

Read More
Laboratory Automation & Robotics

Eli Lilly’s Triple Agonist Achieves 16.8% Weight Loss in Phase 3 Trial for Type 2 Diabetes, Signaling Major Therapeutic Advance

Lana Keisha Mar 19, 2026 0

Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…

Read More
Pharmaceutical R&D

Excalipoint Therapeutics Launches with $68.7 Million Seed Funding to Advance Novel T-Cell Engager Pipeline

Teuku Ryan Mar 18, 2026 0

Chinese biotech startup Excalipoint Therapeutics has officially launched with a substantial $68.7 million in seed funding, positioning itself to accelerate…

Read More
Stem Cell & Regenerative Medicine

Researchers Create First Fully Human 3D Bone Marrow Model to Advance Cancer Treatment and Reduce Animal Testing

Dwi Wanna Mar 14, 2026 0

In a landmark development for regenerative medicine and oncology, scientists at the University of Basel and University Hospital Basel have…

Read More

Posts pagination

1 … 3 4
WHO Introduces Faster, More Accessible TB Testing Strategies While CDC Maintains a Targeted, Risk-Based Approach in the United StatesMolecular Architects of Fertility Osaka University Researchers Identify Key Protein Interaction Regulating Sperm DevelopmentHow digital tools and AI are accelerating drug discoveryCU Boulder Researchers Unveil Revolutionary Material Design Based on the Mechanics of Entangled Office Staples
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
The oral exposure challenge in PROTACs: What drug developers need to solve earlyAttention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological LandscapeHarmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum InformationSolstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Sep 12, 2026
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026
Advanced Materials Science
Harmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
Nila Kartika Wati Sep 12, 2026
Pharmaceutical R&D
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Teuku Ryan Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ